Skip to main content

Table 2 Biomarkers in the head and neck carcinoma

From: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

Biomarkers

Prognostic

Predictive

Epstein barr virus in endemic nasopharyngeal cancers

Validated

Validated

HPV

Validated

Potential

PET imaging post treatment

Validated

Potential

Hypoxia

Potential

Potential

EGFR (potential predictive factor for accelerated radiotherapy)

Potential

Not validated

TP53 gene mutation

Potential

Potential

Gene expression profiling

Potential

Potential

Immune checkpoint related

Potential

Potential